IRIS

High efficacy of beta-blockers in Long QT Syndrome type 1: contribution of non-compliance and QT-prolonging drugs to the occurrence of beta-blocker treatment “failures”.

SCHWARTZ, PETER;CROTTI, LIA;PRIORI, SILVIA GIULIANA;Napolitano C;
2009-01-01
2009
Cardiovascular & Hematology Research covers all levels of investigation into the normal and pathogenic functions of the heart, vasculature, and soluble blood components. Cell biology of vascular tissue and formed elements of blood, biochemical regulation of thrombosis, therapeutic strategies for treatment of cardiac and vascular diseases are also considered. Resources on hematologic oncology are excluded and are placed in the Oncogenesis & Cancer Research category.
CIRCULATION
sì
Sì, ma tipo non specificato
Inglese
Internazionale
STAMPA
119
215
221
LONG QT SYNDROME; BETA-BLOCKER
12
info:eu-repo/semantics/article
262
Vincent, Gm; Schwartz, Peter; Denjoy, I; Swan, H; Bithell, C; Spazzolini, C; Crotti, Lia; Piippo, K; Lupoglazoff, Jm; Villain, E; Priori, SILVIA GIULI...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
none
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11571/144712
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact